# Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee

> **NCT05419856** · PHASE1 · COMPLETED · sponsor: **4Moving Biotech** · enrollment: 34 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** 4P-004
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05419856
- **Lead sponsor:** 4Moving Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-09
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05419856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05419856, "Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05419856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*